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Resumo 
 
 Regista-se, nas últimas décadas, em estreita relação com o aumento do número de 
indivíduos imunocomprometidos, uma maior incidência de infeções mediadas por espécies de 
Candida [5]. Ainda que a maioria das infeções seja provocada por Candida albicans, é também 
observado que a emergência de infeções originadas por outras espécies do género Candida tem 
vindo a aumentar [5,6,9], sendo Candida glabrata uma das mais frequentemente isoladas e a segunda 
maior responsável pelos casos diagnosticados de candidiases[6,7,8].  
 A capacidade intrínseca de resistir às pressões exercidas pelas condições de stress 
impostas pelo hospedeiro é um dos factores que tem contribuído, seguramente, para o sucesso de 
Candida glabrata naquelas infeções [14,15]. Embora não seja capaz de formar hifas verdadeiras, como 
C. albicans, C. glabrata consegue, através da formação de biofilmes, aderir às células do hospedeiro, 
bem como a diferentes superfícies artificiais. Esta capacidade de adesão é, em grande parte, 
mediada pelas adesinas, nomeadamente as pertencentes à família EPA (Epithelial Adhesin Family), 
cujos membros CgEpa1, CgEpa6 e CgEpa7 foram já caracterizados [11]. A expressão de enzimas 
extracelulares, como proteases e hemolisinas, é igualmente crucial no processo de infeção, já que 
essas enzimas auxiliam a penetração nos tecidos, a evasão do sistema imunitário e a obtenção de 
nutrientes por parte daquela levedura [12,13]. C. glabrata mostrou, ainda, ser capaz de tolerar o 
confronto com células do sistema imunitário, como os macrófagos, usando-os como local imuno-
privilegiado para a replicação, e com péptidos antimicrobianos, produzidos pelas células do 
hospedeiro para eliminar agentes patogénicos invasores [9,48]. Acresce dizer que a mesma levedura 
evidenciou, também, a capacidade de sofrer alterações cromossómicas, como perdas de 
cromossomas, rearranjos, translocações e fusões, que contribuem para uma alta diversidade entre a 
população que, de outra forma, poderia ser afetada pela sua incapacidade de reprodução sexuada 
[1,15].  Esta plasticidade genómica serve como mecanismo compensatório que lhe permite adaptar-se 
a um ambiente nefasto e em constante mudança, como o que poderá encontrar no hospedeiro.  
 Como agravante, esta espécie é conhecida pela resistência adquirida a antifúngicos 
usados no tratamento das infeções [56,57]. Revela-se particularmente preocupante o facto dessa 
ocorrência se dar de forma cada vez mais acelerada, uma vez que, por exemplo, a resistência a 
equinocandinas e ao fluconazole, por parte de isolados de C. glabrata, aumentou de zero casos, 
entre 2001 a 2004, para 9.3% dos casos entre 2006-2010 [57]. 
 Os mecanismos que explicam estas impressionantes capacidades de resistência a 
drogas e de resiliência dentro do hospedeiro, que têm vindo a ser estudados, podem, entre outros 
factores, ser mediados pela capacidade de extrusão de compostos tóxicos por bombas de efluxo, 
incluindo as pertencentes à superfamília MFS (Major Facilitator Superfamily), exaustivamente 
estudadas em S. cerevisiae [61,62,68]. Devido à proximidade entre S. cerevisiae e C. glabrata, muitos 
dos referidos transportadores identificados para S. cerevisiae têm homólogos em C. glabrata  [5,61,62,68].  
É o caso dos transportadores Dtr1 e Tpo4, nos quais se centra esta tese. 
 Em S. cerevisiae, o transportador Dtr1, formado por 572 aminoácidos, é sintetizado no 
retículo endoplasmático e levado para a membrana do pró-esporo, a sua última localização [69]. Na 
ausência deste transportador, a composição da superfície do esporo é alterada e o transporte, quer 
da molécula bisformil-ditirosina, importante componente da superfície do esporo, quer de ácidos 
fracos, é fortemente alterado [69]. A tolerância a estes ácidos é muito importante para a proliferação 
eficaz, dentro do hospedeiro, das espécies de Candida, porque, no trato vaginal, existem 
concentrações significativas de ácido acético e lático. [111]. Sublinhe-se que relações sinergéticas 
entre a resistência a ácidos fracos e a antifúngicos têm vindo a ser descritas, quer para C. albicans 
quer para C. glabrata, reforçando, assim, a importância dos ácidos no contexto da virulência e da 
infeção [112,113]. 
 No caso do transportador Tpo4, identificado em S. cerevisiae, observou-se ser 
determinante na resistência a poliaminas, pois regula a sua presença no citoplasma das células de 
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levedura [71]. A assimilação de poliaminas tem vindo a ser estudada para outros transportadores da 
família Tpo, por exemplo o CgTpo3 de C. glabrata, envolvido na resistência a azóis e na extrusão de 
poliaminas para o meio extracelular [63]. A capacidade de inter-relação, entre a homeostase das 
poliaminas e a resistência a antifúngicos utilizados nas terapias, ganha especial relevo no contexto da 
infeção no trato urogenital humano, uma vez que aí existem altas concentrações de diferentes 
poliaminas. Infere-se, portanto, que a resistência a poliaminas pode ser importante para permitir a 
colonização do epitélio urogenital e melhorar a capacidade de virulência neste local adverso [63].  
 Trabalhos anteriores, desenvolvidos no grupo BSRG, demonstraram que ambos os 
transportadores, CgDtr1 e CgTpo4, pertencentes à família de Drug:H+ Antiporter, estavam 
relacionados com a letalidade observada no modelo de infeção Galleria mellonella.  
 Os modelos de infeção, dentro dos quais se insere Galleria mellonella, têm-se revelado 
extremamente importantes no estudo dos mecanismos de infeção por parte de leveduras e bactérias. 
G. mellonella torna-se especialmente relevante porque tem um sistema imunitário muito semelhante 
àquele que é inato nos mamíferos, onde os hemócitos, semelhantes aos neutrófilos e macrófagos 
humanos, são capazes de fagocitar e matar agentes patogénicos pela produção de espécies reativas 
de oxigénio e enzimas líticas [56]. A sua fácil manipulação, a inexistência de constrangimentos no 
controlo do processo de inoculação, bem como os resultados promissores que advêm da utilização 
deste modelo, elegem-no como primeira opção, dentro do grupo BSRG, para estudar interações entre 
agentes patogénicos e o hospedeiro. 
 Neste trabalho, a caracterização funcional do CgDtr1 e do CgTpo4 foi realizada focando-
se no seu papel em respostas ao stresse, relevantes no contexto de infeção e de interação levedura-
hospedeiro. A deleção do CgDTR1 revelou limitar a capacidade de proliferação das células de C. 
glabrata, após a injeção, na hemolinfa de larvas de G. mellonella. Adicionalmente, resultados para o 
mutante de deleção Δcgdtr1 mostraram concentrações ligeiramente menores de células viáveis 
dentro dos hemócitos, os correspondentes em G. mellonella aos macrófagos humanos, quando 
comparadas com as observadas nas células wild-type. Tomando estes resultados em consideração, 
foi estudado o papel do CgDtr1 na tolerância aos stresses associados à resposta mediada pelos 
macrófagos. O transportador CgDtr1 mostrou-se determinante na resistência ao stresse oxidativo e 
aos ácidos fracos, mas não aos antifúngicos. Foi descrito como localizado na membrana plasmática 
de C. glabrata, usando fusão com a GFP, e implicado no decréscimo de acumulação de ácido acético, 
marcado radioativamente. O transportador CgTPO4, não tendo revelado afetar a proliferação de C. 
glabrata na hemolinfa do modelo G. mellonella, foi descrito como interveniente na capacidade de 
resistência à histatina-5, um péptido antimicrobiano humano, semelhante àqueles que fazem parte do 
sistema imunitário primário das larvas de G. mellonella. Tendo em conta a semelhança com o seu 
homólogo em S. cerevisiae, o CgTpo4 foi também descrito como envolvido na resistência a 
poliaminas, mas não a antifúngicos. Este transportador foi localizado na membrana plasmática em C. 
glabrata, usando fusão com GFP, e associado ao decréscimo de acumulação de espermidina, 
marcada radioativamente. 
 Os resultados obtidos no decurso deste trabalho sugerem que o CgDtr1, na virulência de 
C. glabrata em G.mellonella, está associado à sobrevivência da levedura dentro dos hemócitos, pelo 
controlo da concentração intracelular de ácidos fracos, ao passo que o CgTpo4  está relacionado com 
a capacidade de resistência a péptidos antimicrobianos.  
 Estes resultados são promissores na medida em que contribuem para o esclarecimento 
dos mecanismos intervenientes na relação de C. glabrata com o hospedeiro, permitindo, assim, 
redirecionar o estudo dessas relações e, consequentemente, equacionar novas possibilidades 
terapêuticas, preferencialmente mais focadas nas relações que, comprovadamente, existem entre o 
hospedeiro e o agente patogénico.  
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Abstract 
 
 The incidence of Candida sp. related infections has been growing significantly over the 
last couple of decades, mainly due to the increasing numbers of immunocompromised individuals. 
Within these species, Candida glabrata has become the second most frequent cause of candidiasis. 
Part of the success of this species is due to its intrinsic ability to withstand the pressure exerted by 
antifungal drugs and several stress conditions imposed by the host.  
 Earlier work performed at the BSRG has shown that the CgDtr1 and CgTpo4 transporters, 
from the Drug:H+ Antiporter family, are involved in C. glabrata virulence outcome in the Galleria 
mellonella infection model. In this work, the functional characterization of CgDtr1 and CgTpo4 was 
undertaken, with focus on their role in infection-relevant stress responses and in host-pathogen 
interaction. The deletion of CgDTR1 was found to limit the ability of C. glabrata cells to proliferate, 
upon injection, in the haemolymph of the G. mellonella larvae. Additionally, the Δcgdtr1 deletion 
mutant was found to reach a slightly lower concentration of viable cells inside haemocytes, the G. 
mellonella correspondent to human macrophages, when compared to the wild-type cells. Taking these 
results into consideration, the role of CgDtr1 in the tolerance to macrophage associate stresses was 
studied. CgDtr1 was found to be a determinant of resistance to oxidative and weak acid stress, but not 
to antifungal drugs. This transporter was found to be localized in the C. glabrata plasma membrane, 
using a GFP fusion, and to mediate the decreased accumulation of radiolabelled acetate. CgTPO4 
was not found to affect C. glabrata proliferation in G. mellonella haemolymph, but was found to confer 
resistance to histatin-5, a human antimicrobial peptide, similar to those found to be part of the primary 
immune-system of G. mellonella larvae. Similar to its S. cerevisiae homolog, CgTpo4 was also found 
to confer resistance to polyamines, but not to antifungal drugs. This transporter was found to be 
localized in the C. glabrata plasma membrane, using a GFP fusion, and to mediate the decreased 
accumulation of radiolabelled spermidine. 
 Altogether, these results suggest that the role of the CgDtr1 in C. glabrata virulence 
against G. mellonella is associated to its contribution to survival inside haemocytes, through the 
control of intracellular concentration of weak acids, while that of CgTpo4 appears to be related to its 
role in antimicrobial peptide resistance. 
 
Key-words: C. glabrata, virulence, Drug:H+ antiporter, Galleria mellonella, infection 
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1. Thesis Outline 
 Candida glabrata is one of the most frequently isolated non- albicans pathogenic Candida 
species, accounting for nearly 20% of the infections registered in both Europe and North America [6,7,8]. 
Its success in causing infection is mainly due to high intrinsic stress tolerance that enables this yeast 
to resist confrontation with the immune system and withstand prolonged harmful conditions such as 
nutrient starvation and oxidative stress [14,16,9]. Transporters of the Drug:H+ antiporter family, belonging 
to the Major Facilitator Superfamily (MFS), well characterized in the model yeast Saccharomyces 
cerevisiae, are known to take part in multi-drug resistance as well as in other important physiological 
stress response mechanisms, including weak acid and polyamine resistance and transport [58,61,62]. At 
present, not much is known about these transporters and their role in stress responses and host-
pathogen interaction in C. glabrata. But for some years, the Biological Sciences Research Group has 
been characterizing the MFS transporters in both S. cerevisiae and, more recently, in Candida 
glabrata [60,61,62,63,68,70]. This work, thus, intends to contribute to the functional characterization of two 
drug:H+ antiporters, CgDtr1 and CgTpo4, particularly focusing their role in the tolerance to different 
stresses related to host-pathogen interactions.  
 The CgDtr1 and CgTpo4 transporters were preliminarily studied by Miguel Cacho Teixeira’s 
team (Santos, R. unpublished results), within the BSRG group, reaching the conclusion that they were 
both involved in early biofilm development and in the virulence outcome when interacting with the 
Galleria mellonella infection model. In this work, we planned to further evaluate the molecular basis of 
these observations. The knowledge gathered for the CgDtr1 and CgTpo4 homologs in S. cerevisiae 
[70,71] was further used to complete the functional analysis of their C. glabrata counterparts.   
 This thesis is organized into five chapters. The first is an introduction to the Candida glabrata 
epidemiology and pathology, virulence traits, drug-and stress-resistance.  
 The second part is composed of the materials and method used for the development of this 
work, followed by the results, that compose chapter 3.  
 In chapter 4, the integration of the obtained results is performed, within the framework of 
current knowledge on the subject.  
 Finally, the fifth chapter is composed by the future perspectives where the unanswered 
questions raised by the results are highlighted. In this section proposals for future work are brought to 
light, with the main purposed of further trying to understand the complex mechanisms underlying the 
action of the studied drug:H+ antiporters that were found to stand in the cross-road of drug resistance 
and pathogenesis in C. glabrata.   
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2. Introduction 
 
2.1. Candida glabrata as an Opportunistic Pathogen 
 The haploid yeast Candida glabrata (H.W.Anderson) S.A.Mey. & Yarrow, previously known as 
Torulopsis glabrata (H.W.Anderson) Lodder & N.F.de Vries[1], is considered to be part of the Candida 
genus, even though it is phylogenetically closer to Saccharomyces cerevisiae (E.C. Hans) Meyen 
(Figure 1) [2]. Although most S. cerevisiae genes have orthologs in C. glabrata and similar 
chromosomal structure [3], C. glabrata  seems to have lost some genes during the evolutionary 
process, like those involved in galactose, and some related to phospate, nitrogen and sulfur 
metabolism, most likely due to its adaptation to the mammalian host [4]. 
 
  
 
 
 
 
 
 
  
 The frequency of Candida infections has been increasing over the years, largely due to the 
increasing size of the at-risk populations, which includes transplant recipients, cancer patients and 
other patients undergoing immuno-suppressive therapy [5]. Candida species are among the top 10 
most frequently isolated nosocomial bloodstream pathogens, with annual incidence rates of 1.9 up to 
4.8 cases, in Europe, and 6.0 to 13.3 cases, in the United States, per 100 000 inhabitants [5]. 
 C. albicans (Robin) Berkhout is the predominant cause of invasive candidiasis, representing 
50% to 70% of all cases, however the epidemiology of Candida infections has evolved, with 
longitudinal studies showing that a higher proportion of patients are now infected with non-albicans 
Candida species [6]. These include C. glabrata, among other examples, which is now accounting for 15 
to 20% of the diagnosed cases of candidiasis in Europe [7] and for 20% in North America [8]. This 
dramatic change has been partly related to the selection of less susceptible Candida strains by the 
widespread use of antifungal drugs [5].  
 Despite being incapable of switching to true hyphal growth, such as observed in C. albicans, C. 
glabrata is a successful pathogen [9] . C. glabrata is able to attach to host cells and form biofilms, 
function that is partly mediated by a large family of epithelial adhesins (Epa proteins), but also by other 
adhesin-like cell wall-anchored proteins. Adhesins can be divided in sugar-sensitive (lectin-like) or 
Figure 1: Phylogenetic tree of Candida species representation. (adapted from Fitzpatrick et al, 2010) 
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sugar-insensitive, and they mediate the adherence either to the epithelium or to abiotic surfaces [10]. In 
C. glabrata, only CgEpa1, CgEpa6 and CgEpa7 have been fully characterized [11]. 
 Secretion of extracellular enzymes, such as proteases, lipases, phospholipases, esterases 
and hemolysins, is considered a virulence factor in Candida species. They enable pathogens to 
penetrate tissues and obtain nutrients [12]. They also play a role in the evasion of the immune system 
by cleaving immune regulatory proteins or deregulating the cascade-activated homeostatic host 
systems, such as blood coagulation or antibodies formation pathways [13]. Hemolysins, for instance, 
induce rupture of erythrocytes, the most common blood cell. Besides the obvious damage this rupture 
causes, it also releases iron, which is needed for the growth and pathogenicity of yeasts [13].  
   C. glabrata also appears to undergo chromosomal alterations, including chromosome loss, 
rearrangements, translocations, chromosome fusions and interchromosomal duplications leading to 
distinct karyotypes [1]. It is even capable of de novo chromosomal generation [15]. All these properties 
lead to wide population diversity. The genomic plasticity may serve as compensatory mechanism to 
enable fast adaptation to a changing host environment and compensate for the absence of a sexual 
cycle [8]. 
   
2.2. Immune Evasion Strategies and Macrophage Recognition 
 C. glabrata has a high intrinsic stress tolerance, which allows her to sustain prolonged 
starvation periods and to withstand oxidative stress [14]. In vitro, this pathogen can tolerate the 
confrontation with host immune cells, especially macrophages. Indeed, a significant fraction of cells is 
not only able to survive but also replicate inside human macrophages [9]. 
 Macrophages are professional phagocytes of the monocytic lineage, which can be found in 
almost all tissues and are abundant in mucosal surfaces. The first contact between a phagocytic cell 
and a microbe is mediated by host receptors, including pattern recognition receptors (PRRs) which 
detect conserved basic molecular components of microorganisms, the pathogen associated patterns 
(PAMPs), and opsonic receptors which recognize opsonized microbes [17]. Recognition of microbial 
ligands by macrophage receptors activates a series of intracellular signalling pathways that lead to 
phagocytosis. Engulfed microorganisms are trapped in a plasma membrane-derived vacuole, the 
phagosome. This premature compartment lacks the ability to break down particles or kill pathogens. 
During the maturation process, a series of fusion events with compartments of the endosomal 
pathway takes place, and allows the phagosomes to become more acidic and hydrolytically active. 
Nutritional limitation and oxidative and non-oxidative antimicrobial mechanisms lead to death or 
growth restriction of engulfed microorganisms [9]. 
 Since the host defence mechanisms, such as the innate immune phagocytic cells, are multi-
facetted, a number of different evasion strategies have evolved. These include avoidance of contact 
with macrophages, rapid escape from host immune cells, ability to withstand macrophage 
antimicrobial activities and, most importantly, use of macrophages as an intracellular niche for 
protection from other immune cells [9]. A frequent strategy is to mask the immune stimulatory 
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components of the cell wall to avoid recognition and activation by macrophages [18;19]. The cell wall of 
yeasts is composed, in addition to other elements such as chitin, by β-glucans and proteins protected 
by an external layer (namely, linear polymers of mannose). β-1,3-glucan has an important role in the 
recognition by the immune system since it is recognized by the dectin-1 receptor on macrophages [20]. 
Intact C. albicans cells have less interaction with this receptor, since they are protected by the mannan 
layer. But, when the cell wall suffers any damage, β-1,3-glucan is exposed. When that happens, the 
dectin-1 receptor quickly recognizes and binds to it, allowing the activation of macrophages and the 
production of inflammatory cytokines such as TNF-α [21]. 
 Candida glabrata displays a similar response, however, binding to macrophages is also partly 
mediated by adhesin Epa1 [22]. Therefore, mutants with defects in protein glycosylation are killed more 
efficiently by macrophages [23,24]. Recently, dectin-2 receptor was regarded as important in host 
defense against this pathogenic yeast. Knock-out mice for this receptor were more susceptible to 
infection by C. glabrata and phagocytosis decreased in its absence [25]. In addition to recognition of 
pathogens, another important feature of the immune system is its ability to effectively create an 
inflammatory response through chemical mediators, especially proinflammatory cytokines such as 
TNF-α. In C. glabrata, TNF-α or other cytokines such as IL1, IL6, IL8 and IFNγ are weakly induced 
upon infection. The only cytokine that appears to be induced upon infection is GM-CSF [26]. This 
cytokine functions as a macrophage activator and induces their recruitment. Since C. glabrata has the 
ability to survive and replicate inside macrophages (Figure 2), it is reasonable to believe that attracting 
more macrophages to the site of infection is an invasion strategy [26]. 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Fluorescent Microscopy Images show Candida glabrata replicating inside macrophages 
Yeast cells stained with fluorescein isothiocyanate (FITC, shown in green) prior to phagocytosis. The dye is  not transferred to daughter cells 
allowing differentiation between mother cells (white1022 arrows) and newly formed intracellular daughter cells (red arrows) within macrophages  
after 8 h of co-incubation. Image reported in Kasper et al, 2015.  
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2.3. Candida glabrata Survival within the Macrophage 
 After phagocytosis, microorganisms are internalized in the phagolysosome, the central 
compartment for the antimicrobial activity of these first line defence cells.  
 C. glabrata strategy lies in preventing the maturation and acidification of this compartment. So, 
this yeast resides in a modified phagosomal compartment that acquire early and late endosomal stage 
markers (EEA 1, early endosomal antigen 1, and LAMP-1, lysosomal-associated membrane protein 1, 
respectively), but not phagolysosomal markers (for instance, cathepsin D or signal of lysosomal 
fusion). Therefore, phagosomes that internalize viable yeasts are only weakly acidified [9,27]. If, 
however, we considered heat-killed yeasts and their exposure to macrophages, they are internalized 
in a compartment with all phagolysosomal properties. This is indicative that for the modification from 
phagosome to phagolysosome either a heat-labile surface factor is required or the metabolic activity of 
the yeast is needed [9,27]. 
 In addition, it was recently observed for C. albicans, that the metabolization of amino acids as 
an alternative carbon source, with consequent ammonia extrusion, is implicated in the alkalinization 
and neutralization of the phagosome environment [9]. Candida glabrata is also able to alkalinize its 
environment in vitro when resorting to the use of amino acids in the absence of glucose. The Mnn10 
and Mnn11 mannosyltransferases are important for this environment alkalinization and prevention of 
phagosome acidification, suggesting that they are included in the strategy to raise the environmental 
pH [9]. 
 Another possible strategy lies within the dectin-1 mediated Syk signaling. C. glabrata viable 
cells can induce a less pronounced Syk activation, implying that a reduced signalling could underlie 
the delivery of viable yeasts to non-matured phagosomes [9]. Still, it is not entirely clear or accepted 
that this yeast needs to prevent phagosome maturation or modify its pH to survive. The truth is that, in 
vitro, this yeast can grow unaffected when exposed to acidic pH, as low as 2.0 [28]. Even so, the 
combination of pH with an arsenal of antimicrobial properties within the macrophage may restrict their 
survival. That is, it is more likely that the observed effects result from a combination of factors. 
 The production of reactive oxygen species (ROS), along with a low pH value, represent a 
central aspect of the antimicrobial response in macrophages. Its production is driven by the NADPH 
oxidase complex that generates superoxide, hydroxyl anions and radicals [29]. However, C. glabrata 
has a high resistance to oxidative stress. This resistance is partly mediated by Cta1 catalase 
expression [30]. Nevertheless, in vitro response to oxidative stress also includes thioredoxin 
peroxidases (Tsa1 and Tsa2) thioredoxin reductases (Trr1 and Trr2), thioredoxin cofactor (Trx2), 
glutathione peroxidase (Gpx2) and superoxide dismutases (Sod1 and Sod2) [31]. During in vitro 
experiences of C. glabrata interaction with macrophages, Sod1 was found to confer resistance to 
killing in the absence of Yap1 mediated signalling. In addition, the CTA1-reporter gene was found to 
be induced after phagocytosis, indicating that macrophage interaction leads to oxidative stress 
sensing by C. glabrata and to the subsequent  activation of Cta1 [9]. Studies on human and murine 
macrophages have shown that C. glabrata suppresses ROS production by phagocytes. Even so, 
NADPH oxidase is activated by recognition and phagocytosis of microorganisms, even before the 
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phagosome is sealed [9]. Thus, it is not expected that incomplete phagosome maturation cause a 
decrease in ROS induction. ROS suppression is currently viewed as an active down-regulation of 
macrophage ROS production by this pathogenic yeast, as an immune evasion strategy [27,9]. While a 
correlation between phagocytosis-associated oxidative metabolism and killing has been described for 
C. albicans, the role of ROS in C. glabrata killing is still unclear. The high intrinsic resistance to 
oxidative stress along with the fact that inhibition of ROS production in macrophages did not increase 
yeast survival [32], suggests that ROS may play a secondary role in direct killing of C. glabrata. 
 To be able to survive and replicate in the phagosome, C. glabrata has to adapt to the 
surrounding environment , not only low pH values and oxidative stress but also nutritional restrictions. 
This includes adjustment to the use of alternative carbon sources, as well as nitrogen deprivation [9]. 
The transcriptional response of C. glabrata to phagocytosis reflects up-regulation of genes encoding 
for enzymes of the glyoxylate cycle, gluconeogenesis, and β-oxidation of fatty acids, as well as down-
regulation of glycolysis. These responses suggest the triggering of alternative carbon source 
metabolism [33,34]. Also, down-regulation of protein synthesis and up-regulation of amino acid bio-
synthetic pathways, and amino acid and ammonium transport genes, suggests that the yeast 
undergoes deprivation of nitrogen. In addition, methylcitrate cycle genes, important for the degradation 
of fatty acid chains which enables the use of lipids as alternative carbon source, was found to be up-
regulated in these conditions [33,34]. 
 Aside from carbon and nitrogen, trace elements, such as iron, are important for C. glabrata 
growth. Iron is an essential transition metal which serves as a cofactor for many enzymes and is 
required for numerous biochemical processes, including cell respiration and metabolism, oxygen 
transport and DNA synthesis [35]. Thus, it is not surprising that the host sequesters iron from 
extracellular spaces, to challenge organisms with micronutrient limitations, a process known as 
nutritional immunity [36]. C. glabrata does not use ferritin or transferrin as iron sources, and is not able 
to use heme or hemoglobin. However, it expresses one siderophore-iron transporter called Sit1. Sit1 
mediated binding increases fitness and survival during exposure to macrophages. Iron availability and 
acquisition are important determinants of intracellular survival and replication in macrophages. Recent 
studies showed that 11 out of 23 mutants identified for reduced survival within macrophages showed 
defects in growth under iron limitation [32].  
 Depending on the organism there are a number of possible strategies to evade the host, and 
that also includes possible exit strategies from macrophages. These strategies include non-lytic 
exocytosis, observed for C. albicans and C. neoformans (San Felice) Vuillemin (assexual morph 
of Filobasidiella neoformans Kwon-Chung), induction of host cell death by apoptosis or pyroptosis or 
caspase-dependent early lytic pro-inflammatory cell death [9]. After phagocytosis, Candida albicans 
rapid hypha formation is activated. Its triggering is important for initiation of inflammatory responses 
and also mechanical damage and escape from the macrophage [9]. C. glabrata grows predominantly in 
the yeast form and only forms pseudohypha under certain conditions, particularly nitrogen deprivation. 
However, microevolution experiments with permanent exposure of C. glabrata to macrophages for 
several months selected populations with genetic changes that caused a higher pseudohypha-like 
growth, greater mechanical damage of macrophages and faster escape [37]. 
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 During the interaction with human macrophages derived from monocytes, C. glabrata remains 
intracellular for 2-3 days without causing obvious damage to macrophages or inducing cell death 
[9].The replicating yeast are still surrounded by  membrane and are not released in to the cytoplasm, 
as indicated by detection of LAMP-1 (lysosomal-associated membrane protein) around the ingested 
yeast cells after 24 hours. After 2-3 days, macrophages with increased fungal burden were observed 
to lyse and release yeasts into the surrounding medium [27]. Even so, the time of macrophage burst is 
dependent on the initial yeast-to-macrophage ratio and the macrophage cell type [9]. 
 
2.4. Virulence traits for the establishment of infection: biofilm formation and 
antimicrobial peptide resistance 
Besides phagocytosis, in the event of Candida infection, the adherence to host surfaces is 
required for colonization and infection establishment [38].Adherence contributes to the organism 
persistence inside the host, which is crucial for the disease development strategy. Candida species 
are well known for its adherence capacities and biofilm formation, not only within the host, but also 
attached to medical devices [38,39]. 
Cell surface proteins, like adhesins encoded by the EPA gene family, are known to promote 
specific adherence. But the initial attachment of Candida cells to the host is not only promoted by cell 
division, proliferation and adherence, but is also dependent on biofilm development [40]. Biofilms are 
surface-associated communities of microorganisms involved by an extracellular matrix, and they 
present the most prevalent growth form amoung different microorganisms [38,41]. Since this structure 
has been known to confer resistance to antifungal drugs, by limiting drug penetration, and protection 
from the host immune system, biofilm formation is considered one of the most important virulence 
factors used by pathogenic yeast cells, such as C. glabrata [42,43]. Furthermore, they have also been 
associated with higher morbidity and mortality rates [44]. 
C. glabrata is known to produce lower quantities of biofilm mass when compared with other 
NCAC (non-C. albicans Candida) species but, is has been showed that higher biofilm biomass is 
produced, by this yeast, on artificial surfaces, such as silicon in the presence of urine, then in SDB 
medium when compared with C. parapsilosis (Ashford) Langeron & Talice, 1932 or C. tropicalis 
Berkhout, 1923 [41,45]. C. glabrata biofilm matrices were already characterized has having high levels of 
both proteins and carbohydrates, concordant with what has been seen for C. albicans whose biofilm 
matrix which is composed mainly by carbohydrates, proteins, phosphorus and hexosamines [41]. It is 
also important to highlight that C. albicans biofilm is formed by a mixed population of budding-yeast 
and hyphae, but no filamentation has yet been observed in C. glabrata biofilms [46,47]. 
In order to fully establish a functional biofilm, the first step is the adherence of yeast cells to 
host surfaces or abiotic medical devices. After adherence, formation of colonies, secretion of 
extracellular polymeric substances, maturation in a three-dimensional structure and cell dispersion 
have to occur. In the following scheme (Figure 3) the various steps behind biofilm formation are 
detailed. 
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Besides biofilm development, another important virulence trait is the ability to resist the action 
of antimicrobial peptides. Antimicrobial peptides are small, positively charged, amphipathic molecules 
that may be composed by a variety of amino acids and have various lengths (from 6 to 100 amino 
acids) [48]. In humans, the most prominent innate antimicrobial peptides are the cathelicidins and 
defensins, produced by immune system cells, and the histatins produced and secreted into the saliva 
by the parotid, mandibular and submandibular salivary glands [48]. 
Most antimicrobial peptides work directly against microbes through a mechanism that involves 
membrane disruption and pore formation, that eventually leads to the efflux of essential ions and 
nutrients [49]. The mechanism behind the association with and permeabilizing off the microbial cell 
membranes is not entirely clear, but these peptides are proposed to bind to the cytoplasic membrane, 
creating micelle-like aggregates, leading to a disruptive effect (Figure 4) [48].  Nonetheless, studies 
have been indicating the presence of additional or complementary mechanisms such as intracellular 
targeting of cytoplasmic components crucial to cell physiology functions [48]. Thus, the initial interaction 
between peptides and microbial cell membranes would allow them to penetrate inside the cells to bind 
to intracellular molecules, resulting in the inhibition of cell wall biosynthesis, and processes involving 
DNA, RNA and protein synthesis and function [50,51] . These modes of action, combined with a broad 
Figure 3: Scheme representing the three major phases for biofilm development. Resumed phases and main 
factors involved in biofilm formation are presented. Phases from adhesion to mature biofilm development are 
specified taking into account participating molecules and main mechanisms involved.  (adapted from Yeater et al, 
2007) 
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range of lethal activity in a short period of time, corroborate the hypothesis that antimicrobial peptides 
are excellent candidates for the development of novel therapeutic agents [48].  Therefore, the 
acquisition of resistance against their killing activity is crucial for yeasts, and other pathogenic 
microorganisms, to establish a successful infection.    
 
 
 
 
 
 
 
 
 
 
 
 
 
2.5. Infection Models to Study Virulence of Candida glabrata 
 Historically, there has been little interest in developing animal models for C. glabrata infections, 
despite the emergence of both systemic and mucosal infections [52].  Even so, different mouse models 
of oral, vaginal, gastrointestinal, intraperitoneal and intravenous bloodstream infections have been 
developed  [53].  During systemic mouse infection, fungal dissemination spreads to different organs, 
such as brains, kidneys, lungs and even heart, which shows that Candida glabrata is highly adaptable 
and able to colonize many niches [52,53].  Grating this, different mouse models have been applied to 
study the virulence of C. glabrata  gene deletion mutants. These studies analyze fungal burden and 
not host mortality, due to low mortality of mice after infection, since even high fungal burden still 
causes low tissue damage and low inflammation responses (Kasper et al; 2015). That being 
established, the respective genes should be termed fitness factors rather than virulence factors of C. 
glabrata [9].   
 Additionally, non-vertebrate models, such as Drosophila melanogaster, Caenorhabditis 
elegans and Galleria mellonella have also been established for this yeast. These offer a number of 
advantages over mammalian vertebrate models due to economy of size, ease of handling and ethical 
issues [54,55].   
 Galleria mellonella larvae, for instance, bears several advantages: they are cheap to acquire 
and easy to keep, their size simplifies infection and the inoculation process via syringe allows control 
Figure 4: Mechanisms modes of action for antimicrobial peptides in microbial cells. (A) Disruption of cell 
membrane integrity: starting with random insertion into the membrane, followed by alignment of hydrophobic 
sequences and removal of membrane sections and pore formation. (B) Inhibition of DNA synthesis. (C) Blocking of 
RNA synthesis. (D) Inhibition of enzymes necessary for linking of cell wall structural proteins. (E) Inhibition of 
ribosomal function and protein synthesis. (F) Blocking of chaperone proteins necessary for proper protein folding. (G) 
Targeting of mitochondria: starting with inhibition of cellular respiration and induction of ROS formation and 
disruption of mitochondrial cell membrane integrity and efflux of ATP and NADH. (adapted from Peters et al, 2010). 
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of the amount of pathogen applied. Plus, the larvae can be incubated at a range of various 
temperatures which may go up to 37ᵒC [55]. 
 The larval immune system has high similarity to the mammalian innate immune system. The 
haemocytes, phagocytic cellular components similar to neutrophils, are able to phagocyte and kill 
pathogens by producing reactive oxygen species and lytic enzymes [56]. Furthermore, the humoral 
response to infecting microbes involves antimicrobial peptides which were shown to be induced by 
fungal pathogens, and differ from those induced by bacterial pathogens [55]. This feature is very 
important because it allows comparison of data obtained in Galleria virulence studies and murine 
models. Moreover, experiments with G. mellonella grant fast data acquisition, usually with results 
within one or two weeks  [55]. Notwithstanding, there are also disadvantages of this model. After all, the 
genome of G. mellonella has not been fully sequenced and there are no mutant strains available to 
functionally study host response. Plus, they do not have adaptive immune systems, which disable 
further immune response studies. Even so, Galleria mellonella is a useful tool and potent alternative 
infection model to study fungal pathogens.   
 
2.6. Antifungal Drug Resistance  
 During the past three decades antifungal drug resistance became more common and a 
serious concern to the medical community [1]. The proportion of azole resistance in clinical isolates 
across several countries has been shown to increase in the period from 2001 to 2007 [56]. Furthermore, 
resistance to echinocandins of fluconazole-resistance C. glabrata isolates was shown to have 
increase from no cases between 2001-2004 to a 9,3% frequency in the 2006-2010 time period [57]. 
This supports the idea that drug resistance in C. glabrata is developing fast. 
 Classes of antifungals are categorized based on their mechanisms of action. Azoles inhibit the 
cytochrome P450-dependent enzyme lanosterol-demethylase which is crucial for the biosynthesis of 
ergosterol. If ergosterol synthesis is affected, the resulting cell membrane dysfunction impairs 
signalling and transport processes [1]. Polyene antifungals, such as amphotericin B, interact with 
ergosterol in the cell membrane creating pores within the cell membrane causing small molecules to 
leak, resulting in cell death [47]. 5-Flucytosine is an antifungal that interferes with protein synthesis. 
Upon entering the cell through a cytosine permease, this drug is converted into a nucleotide analogue, 
5-flurouracil, which is incorporated into RNA, subsequently interfering with the synthesis of proteins [38]. 
Finally, the more recently introduced antifungals, echinocandins, have become the first line therapy for 
invasive candidiasis. They are able to inhibit β-(1,3)-D-glucan synthase activity, preventing the 
synthesis of β-(1,3)-D-glucan, essential for the composition of the fungal cell wall [47]. 
 Understanding the mechanisms of antifungal resistance is the key to unravel new therapeutic 
options. Resistance may be classified as: primary resistance, when strains are unaffected by the 
antifungal without prior exposure; or secondary resistance, when strains acquire resistance after 
exposure to the drug. Secondary resistance is, by far, the most commonly occurring phenomenon 
among Candida species [1]. 
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 C. glabrata, when compared to other Candida species, is the least susceptible to azoles.  The 
mechanisms behind azole resistance in C. glabrata include changes in P-450 lanosterol demethylase 
enzyme, encoded by ERG11, which results in loss of the drug affinity and/or overexpression of ERG11, 
or activation of drug extrusion catalysed by membrane transport proteins of the ATP binding cassette 
(ABC) superfamily or the Major Facilitator Superfamily (MFS) [1]. Azoles enter the cell by facilitated 
diffusion and bind to the iron present in the heme group of the Erg11 enzyme [58,59]. This N-Fe 
connection restrains the activation of oxygen, which is necessary for the demethylation of lanosterol, 
causing a blockage in the ergosterol production. Consequently, a toxic sterol, known as 14-α-methyl-
3,6-diol, accumulates, causing severe stress in the plasma membrane. This results in a fungistatic 
behaviour in the yeast cells [58].  
 CDR1 and CDR2 genes, encoding drug efllux pumps of the ABC superfamily, are up-
regulated in response to azole exposure. The transcription factor, Pdr1, that regulates the expression 
these genes, is activated through  direct binding to the azole drug molecule, promoting the expression 
of the drug efflux pump encoding genes, being a key azole resistance determinant. Disruption and/or 
removal of the PDR1 gene was found to increase susceptibility to azoles [56]. It was also found that 
Gain Of Function (GOF) mutations in PDR1, identified in azole resistant clinical isolates, enhance 
azole resistance and even virulence in mice models. More recently, a few multidrug transporters of the 
Major Facilitator Superfamily, suggested to act as Drug:H+ Antiporters (DHA), have also been shown 
to confer resistance to azole drugs, especially imidazoles [60,61,62,63]. 
 Little is known about the exact mechanism for resistance to polyene antifungal drugs in C. 
glabrata. A clinical isolate susceptible to polyene treatment was observed to have severe changes in 
the sterol composition of its membrane [64]. This isolate had accumulated numerous sterol 
intermediates that were still able to maintain membrane viability. Further studies showed also that 
nonsense mutations, as opposed to missense, in ERG6 gene generated altered sterol composition in 
the cell membrane [65]. 
  Unlike azole antifungals, secondary resistance to echinocandins has conclusively been 
unrelated to the drug-efflux mechanism as they prove to be poor substrates for most multidrug efflux 
transporters [66]. Instead, echinocandin resistance is caused by interference between the drug and the 
β-1,3-D glucan synthase. The target subunits for this enzyme are encoded by three genes: FSK1, 
FSK2 and FSK3 [67]. Point mutation in the FSK1 and FSK2 are documented as being responsible for 
echinocandin resistance in Candida glabrata. Mutations in "hot spots" of these genes cause a high 
prevalence of amino acid substitutions conferring echinocandin resistance [64]. 
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2.7. The putative Candida glabrata Multidrug Resistance Transporters CgDtr1 and 
CgTpo4  
 
 In this study, the uncharacterized drug:H+ antiporters Dtr1 and Tpo4, encoded by ORF 
CAGL0M06281g and CAGL0L10912g, respectively, were studied in the context of their role in C. 
glabrata virulence.  
First studied in S. cerevisiae, MFS transporters related to mutidrug resistance were grouped 
into two families: Drug:H+ antiporter family (DHA1), including 12 transporters, and Drug:H+ antiporter 
family 2 (DHA2), including 10 transporters. The difference between the two groups is established 
based on the number of transmembrane domains exhibited by each family, 12 for the DHA1 family 
members and 14 for the DHA2 [68]. In Candida glabrata we find 10 predicted members of the DHA1 
and 5 of the DHA2 families. From these, a total of 6 seem to play a role in drug resistance and 
detoxification of the cell, but none of the DHA2 is, up to date, described as being involved in this 
phenomenon [61,62]. 
 Studies in the S. cerevisiae homologs of Dtr1 and Tpo4 were used to guide the functional 
analysis of their C. glabrata counterparts. S. cerevisiae Dtr1 is synthesized in the endoplasmic 
reticulum and then transits to the Golgi complex before reaching the prospore membrane, it's final 
location. Dtr1 is formed by 572 amino acids with 12 predicted transmembrane domains and a large 
cytoplasmic loop in the middle [69). It is encoded by the open reading frame YBR180W, and is 
described as being a membrane dityrosine transporter [70). This role is related to the translocation of 
bisformil-dityrosine from the cytoplasm of the prospore to the maturing spore wall during the wall 
formation process. According to Ferder and colleagues, in the absence of DTR1, the amount of D-L 
dityrosine (present in the spore surface) is reduced to 65% and the racio between this surface 
macromolecule and the soluble spore precursors (DL/LL racio) changes from 0,6 to 0,2. The change 
of this value does not seem to have a major consequence in the sporulation process. Even so, it was 
observed, by the same authors, that the Dtr1 transporter is essential for bisformyl dityrosine molecule 
being able to pass through the plasmatic membrane, on its way to the prospore membrane [70). 
Besides dityrosine, Dtr1 was also shown to play a role in the export of weak acid conjugated bases, its 
expression conferring resistance to this class of compounds  [70). 
 In the case of Tpo4, it was identified in S. cerevisiae as a determinant of resistance to 
polyamines  [71). The polyamine content present in the cytoplasm of yeast cells appears to be tightly 
regulated by Tpo4, but also paralogous transporters including Tpo1, Tpo2 and Tpo3, that guarantee 
an optimal intracellular polyamine content  [71). 
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 3. Materials and Methods 
3.1. Strains and Growth Media 
 Considering the thesis objectives, several strains of Candida glabrata where used and are 
described in Table 1. 
Table 1: C. glabrata strains used to assess stress resistant responses and host-pathogen interactions 
Strain Genotypic Background 
Wild-type Kchr606 
Δcgdtr1 Kchr606_Δdtr1 
Δcgtpo4 Kchr606_Δtpo4 
Wild-type   L5U1 
Wild-type  By4741 
Wt + CgTpo4 By4741_tpo4 
Wt + CgDtr1 By4741_dtr1 
  
 Cells of C. glabrata were cultured in rich Yeast extract Peptone Dextrose (YPD) medium, 
containing per litre: 20g D(+)-glucose (Merck), 20g of bacterial-peptone (LioChem, Inc.) and 10g of 
yeast extract (Difco) and also in Minimal growth medium (MMB) medium, containing per litre: 20g 
D(+)-glucose (Merck), 2,7g ammonium sulphate (Difco) and 1,7g of Yeast-Nitrogen-Base without 
amino acids (Difco). When needed, solid media was obtained by supplementation with 20g/L of agar 
(NzyTech). In what concerns the L5U1 strains, growth media was supplemented with leucine 20x 
concentrated and 1mM of copper solution. As for BY4741, solid and liquid media, was supplemented 
with an amino acid solution containing, per liter, 20 mg methionine, 20 mg histidine, and 60 mg leucine. 
Furthermore, when using this strain in order to express differences between mutated strains, the sugar 
composition of MMB changed from 20g/L D(+)-glucose (Merk) to 1g/L D(+)-glucose (Merk) plus 10g/L 
D(+)-galactose (Sigma). 
 Roswell Park Memorial Institute medium (RPMI) 1640 and Sabouraud Dextrose Broth (SDB) 
media were used for biofilm assays. Such media preparation took 10,4 g of RPMI 1640 (Sigma-
Aldrich), 34,5g of MOPS (Sigma) and 18g of D(+)-glucose (Merk) dissolved in 1L of deionised water, 
adjusted to pH 4.0 and 40g of D(+)-glucose (Merk) and 10g of peptone (LioChem) per litre of 
deionised water, adjusted to pH 5.6, respectively.  
 
3.2. Cloninf of the C. glabrata CgDTR1 and CgTPO4 genes 
3.2.1.  Cloning of the C. glabrata CgDTR1 gene (ORF CAGL0M06281g) 
The pGREG576 plasmid from the Drag & Drop collection [73] was used to clone and express the C. 
glabrata ORF CAGL0M06281g in S. cerevisiae, as described before for other heterologous genes [74]. 
pGREG576 was acquired from Euroscarf and contains a galactose inducible promoter (GAL1), the 
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yeast selectable marker URA3 and the GFP gene, encoding a Green Fluorescent Protein (GFPS65T), 
which allows monitoring of the expression and subcellular localization of the cloned fusion protein. 
CAGL0M06281g DNA was generated by PCR, using genomic DNA extracted from the sequenced 
CBS138 C. glabrata strain, and the following specific primers: 3’ – 
GAATTCGATATCAAGCTTATCGATACCGTCGACAATGAGCACCTCCAGCAACAC - 5’ and 3’ – 
GCGTGACATAACTAATTACATGACTCGAGGTCGACTCAGAAACTGTCTTTAACCC - 5’. The 
designed primers contain, besides a region with homology to the first and last 22 nucleotides of the 
CAGL0M06281g coding region (italic), nucleotide sequences with homology to the cloning site 
flanking regions of the pGREG576 vector (underlined). The amplified fragment was co-transformed 
into the parental S. cerevisiae strain BY4741 with the pGREG576 vector, previously cut with the 
restriction enzyme SalI, to obtain the pGREG576_CgDTR1 plasmid. Since the GAL1 promoter only 
allows a slight expression of downstream genes in C. glabrata, to visualize by fluorescence 
microscopy the sub-cellular localization of the CgDTR1 gene in C. glabrata, a new construct was 
obtained. The GAL1 promoter present in the pGREG576_CgDTR1 plasmid was replaced by the 
copper-induced MTI C. glabrata promoter, giving rise to the pGREG576_MTI_CgDTR1 plasmid. The 
MTI promoter DNA was generated by PCR, using genomic DNA extracted from the sequenced 
CBS138 C. glabrata strain, and the following specific primers: 3’ - 
TTAACCCTCACTAAAGGGAACAAAAGCTGGAGCTCTGTACGACACGCATCATGTGGCAATC - 5’ 
and 3’ - GAAAAGTTCTTCTCCTTTACTCATACTAGTGCGGCTGTGTTTGTTTTTGTATGTGTTTGTTG 
- 5’. The designed primers contain, besides a region with homology to the first and last 19 nucleotides 
of the first 1000 bp of the MTI promoter region (italic), nucleotide sequences with homology to the 
cloning site flanking regions of the pGREG576 vector (underlined). The amplified fragment was co-
transformed into the parental strain BY4741 with the pGREG576_CgDTR1 plasmid, previously cut 
with SacI and NotI restriction enzymes to remove the GAL1 promoter, to generate the 
pGREG576_MTI_CgDTR1 plasmid. The recombinant plasmids pGREG576_CgDTR1 and 
pGREG576_MTI_CgDTR1 were obtained through homologous recombination in S. cerevisiae and 
verified by DNA sequencing. 
3.2.2. Cloning of the C. glabrata CgTpo4 gene (ORF CAGL0L10912g) 
The pGREG576 plasmid from the Drag & Drop collection [73] was used to clone and express the C. 
glabrata ORF CAGL0L10912g in S. cerevisiae, as described before for other heterologous genes [74]. 
pGREG576 was acquired from Euroscarf and contains a galactose inducible promoter (GAL1), the 
yeast selectable marker URA3 and the GFP gene, encoding a Green Fluorescent Protein (GFPS65T), 
which allows monitoring of the expression and subcellular localization of the cloned fusion protein. 
CAGL0L10912g DNA was generated by PCR, using genomic DNA extracted from the sequenced 
CBS138 C. glabrata strain, and the following specific primers: 3’ – 
GAATTCGATATCAAGCTTATCGATACCGTCGACAATGGCCGGTACAAATCAAG- 5’ and 3’ – 
GCGTGACATAACTAATTACATGACTCGAGGTCGACCTATACCATTCTAGAGGAG - 5’. The 
designed primers contain, besides a region with homology to the first and last 22 nucleotides of the 
CAGL0L10912g coding region, nucleotide sequences with homology to the cloning site flanking 
regions of the pGREG576 vector (underlined). The amplified fragment was co-transformed into the 
parental S. cerevisiae strain BY4741 with the pGREG576 vector, previously cut with the restriction 
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enzyme SalI, to obtain the pGREG576_CgTPO4 plasmid. Since the GAL1 promoter only allows a 
slight expression of downstream genes in C. glabrata, to visualize by fluorescence microscopy the 
sub-cellular localization of the CgTPO4 gene in C. glabrata, a new construct was obtained. The GAL1 
promoter present in the pGREG576_CgTPO4 plasmid was replaced by the copper-induced MTI C. 
glabrata promoter, giving rise to the pGREG576_MTI_Cgtpo4 plasmid. The MTI promoter DNA was 
generated by PCR, using genomic DNA extracted from the sequenced CBS138 C. glabrata strain, and 
the following specific primers: 3’ - 
TTAACCCTCACTAAAGGGAACAAAAGCTGGAGCTCTGTACGACACGCATCATGTGGCAATC - 5’ 
and 3’ - GAAAAGTTCTTCTCCTTTACTCATACTAGTGCGGCTGTGTTTGTTTTTGTATGTGTTTGTTG 
- 5’. The designed primers contain, besides a region with homology to the first and last 19 nucleotides 
of the first 1000 bp of the MTI promoter region (italic), nucleotide sequences with homology to the 
cloning site flanking regions of the pGREG576 vector (underlined). The amplified fragment was co-
transformed into the parental strain BY4741 with the pGREG576_CgTpo4  plasmid, previously cut 
with SacI and NotI restriction enzymes to remove the GAL1 promoter, to generate the 
pGREG576_MTI_CgTpo4 plasmid. The recombinant plasmids pGREG576_CgDTR1 and 
pGREG576_MTI_CgTpo4  were obtained through homologous recombination in S. cerevisiae and 
verified by DNA sequencing. 
3.3. Virulence assessment using the Galleria mellonella infection model 
3.3.1. Survival and Proliferation Assessment Assays  
 Galleria mellonella larvae were reared on a pollen grain diet at 25ᵒC in darkness. Larvae 
weighting 250 ± 25 mg were used in survival assays, where the larvae infection was performed as 
described previously [116]. C. glabrata strains were cultured in YPD up to stationary phase and 
harvested by centrifugation in order to achieve an yeast suspension. Each caterpillar was injected  
with 3.5 μL of yeast suspension (with approximately 5x107 cells per injection) via the last left proleg. 
Following injection, 10 and 30 larvae, for survival and proliferation assays, respectively, were placed in 
Petri dishes and maintained in the dark at 37oC over a period of 72 hours. Control larvae were injected 
with PBS (pH 7.4). Regarding the survival assays, caterpillars were considered dead when they 
displayed no movement in response to touch. For proliferation assays, hemolymph was recovered 
with a microsyringe after 1, 24 and 48 hours and plated in YPD medium for CFU counting. Larvae 
injections and hemolymph recoveries were performed in collaboration with Dra. Dalila Mil-Homens, 
Biological Sciences Research Group of the Institute for Bioengineering and Biosciences.  
3.3.2. Haemocyte Interaction Assays 
3.3.2.1.  In vitro cultivation of haemocytes of G. mellonella. 
To isolate G. mellonella haemocytes, hemolymph was collected from larvae previously anesthetized 
on ice and surface sterilized with ethanol by puncturing the larval abdomen with a sterile needle.The 
outflowing hemolymph was immediately transferred into a sterile microtube containing anticoagulant 
buffer (98 mM NaOH, 145 mM NaCl, 17 mM EDTA, 41 mM citric acid [pH 4.5]) in a 1:1 proportion. The 
hemolymph was centrifuged at 250 × g for 10 min at 4°C to pellet haemocytes. The supernatant was 
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taken off, and the pellet was washed twice with 0.9% NaCl and centrifuged at 250 × g for 5 min at 4°C. 
The hemocyte pellet was then suspended gently in 1 ml of Grace insect medium (GIM) (Sigma) 
supplemented with 10% fetal bovine serum, 1% glutamine, and 1% antibiotic or antimycotic solution 
(10,000 U penicillin G, 10 mg streptomycin, 25 mg/liter amphotericin B). Suspended haemocytes were 
counted with a hemocytometer and incubated at 26°C in 24-well plates at a concentration of 2 × 105 
cells/ml. Monolayers of primary Galleria hemocytes were used for experiments the next day. All 
preparations and assays were carried out under sterile conditions. 
3.3.2.2. Determination of in vitro yeast load of haemocytes. 
Cultures of C. glabrata cells were grown in YPD  medium until mid-exponential phase (OD600nm = 0.4-
0.6). The optical density of the cultures was measured, and the appropriate volume was collected to 
have 7 × 102 cells/ml in 0.9% NaCl. Galleria haemocyte monolayer medium was replaced with GIM 
without antimucotics, and then cells were infected with the yeast suspensions. After 1 h of infection at 
37°C, the haemocytes were carefully washed twice with cell culture medium, followed by the addition 
of GIM. The quantification of viable intracellular yeast cells was achieved 1, 4, 24 and 48 hours after 
infection. Cell monolayers were lysed with 0.5% Triton X-100, and CFU were determined by plating 
dilutions of cell lysates on YPD-agar plates followed by incubation at 30°C for 24 h. 
3.4 - Candidacidal assay of Histatin-5 
 To evaluate the effect of CgDTR1 and CgTPO4 expression in Histatin-5 resistance, wild-type, 
∆cgdtr1 and ∆cgtpo4 C. glabrata mutants were batch cultured in YPD until mid-exponential phase 
(OD600nm = 0.4-0.6). Cells were then washed twice and resuspended in sterile PBS and supplemented 
with 35µM of Histatin-5 (Sigma) to an OD600nm = 0.1±0.01. Cell suspensions were incubated at 30ºC 
with under agitation (250 rpm) and cell viability was measured at 30 minutes intervals. Each result was 
compared with the initial cell content of the suspension in order to obtain a survival curve. 
3.5 - Spot and Growth Assays 
 The susceptibility to different test compounds (Table 2) of the parental strains Kchr606, 
BY4741 and L5U1, and derived deletion mutants, was assessed by comparing their growth in MMB or 
YPD medium supplemented or not with inhibitory concentrations.  
Table 2 - Test Compounds considered for Susceptibility Assays 
Compound Class Concentrations 
Acetic Acid Weak acid 85 mM; 100 mM 
Benzoic Acid Weak acid 1m M; 1.5 mM 
Propionic Acid Weak acid 10 mM; 20 mM 
Amphotericin B Polyene 0.17 mg/L; 0.19 mg/L; 0.21 mg/L 
Mancozeb Agricultural Fungicide 5 mg/L; 6 mg/L; 7 mg/L 
 18 
 
Clotrimazole Azole  2.5 mg/L; 5 mg/L; 7.5 mg/L 
Itraconazole Azole 40 mg/L; 60 mg/L; 80 mg/L 
Ketoconazole Azole 10 mg/L; 20 mg/L; 30 mg/L 
Tioconazole Azole 0.1 mg/L; 0.3 mg/L; 0.5 mg/L 
Fluconazole Azole 140 mg/L; 160 mg/L; 180 mg/L 
Miconazole Azole 0.2 mg/L; 0.3 mg/L; 0.4 mg/L 
Spermine Polyamine 8.5 mM 
Spermidine Polyamine 10.5 mM 
Putrescine Polyamine 0.017 mM 
 
 Cell suspensions used as inocula for spot and growth assays were grown in MMB (or YPD for 
polyamines) medium until mid-exponential phase (OD600nm=0,5 ± 0.05). For spot assays, cells were 
diluted in sterile water to obtain suspensions with OD600nm= 0.05 ± 0.005. These and subsequent 
dilutions (1:5, 1:25) were applied as 4 µL spots onto solid MMB or YPD medium, supplemented with 
each respective test compound concentrations. Cell suspensions used for growth assays were 
harvested by filtration and placed in fresh medium supplemented with each respective test compound 
solution concentrations. Growth rate was monitored until attaining stationary phase, over a period of 
80-90 hours. 
3.6 - Acetic acid and Spermidine accumulation assays 
 To analyse the accumulation ratio (intracellular/extracellular concentration) of radiolabeled 
[14C]-acetic acid in C. glabrata Kchr606 and in Kchr606_∆dtr1, cells of the two strains grown in MMB 
growth medium (at pH 4.0) until mid-exponential phase (OD600nm = 0.5 ± 0.05), harvested by filtration, 
washed with fresh medium and finally resuspended in 5 mL of this same medium to obtain dense cell 
suspensions (OD600nm = 0.7 ± 0.05). The same was preformed for the C. glabrata Kchr606_∆tpo4 and 
Kchr606 strains, but since it was a polyamine accumulation assay, YPD growth medium was used. 
This cell suspensions were incubated for 5 min at 30 °C with agitation (150 rev/min). After that time, 
10 µM of [14C]-acetic acid (Amersham Biosciences) were added to the cell suspension together with 
65 mM cold acetic acid (at pH 4.0). The intracellular accumulation of radiolabeled acetic acid was 
followed during 20 minutes by filtering, at adequate intervals, 200 µL of the cell suspension through 
pre-wetted glass microfibre filters (Whatman GF/C). The filters were washed with ice-cold Tris-
Magnesium Sulfate buffer (0.1 M Mes, 41 mM Tris, both from Sigma, adjusted to pH 4.0) and the 
radioactivity was measured in a Beckman LS 5000TD scintillation counter. Extracellular concentration 
of [14C]-acetic acid was estimated by measuring the radioactivity of 50 µL of the culture supernatant. 
Non-specific adsorption of acetic acid to the filters and to the cells was assessed and taken into 
consideration (less than 5% of the total bound-radioactivity). Intracellular concentration of [14C]-acetic 
acid was calculated considering the internal cell volume (Vi) of the two strains constant and equal to 
2.5 mL (mg dry weight)-1 (Carmelo et al.,1997). The same was preformed for the Kchr606_∆tpo4 and 
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Kchr606 strains, using  0.1 µM of [3H]-spermidine (Amersham Biosciences) added to the cell 
suspension together with 8.5 mM cold spermidine (Sigma) and the intracellular accumulation of 
radiolabeled spermidine was followed during 80 minutes. 
3.7 - Biofilm quantification Assay 
 C. glabrata strains were tested for their capacity for biofilm formation recurring to the crystal 
violet method [117]. For that, C. glabrata strains were grown in SDB medium and harvested by 
centrifugation at mid exponential phase. The cells were incoculated in 96-well polysterene titter plates 
(Greiner), where previously had been inoculated RPMI medium (pH=4). Each well was inoculated so 
that the initial OD600nm = 0.05 ± 0.05. Cells were cultivated at 30ºC during 24±0.5 hours with mild orbital 
shaking of 70 rpm. After the incubation time each well was washed three times with 200 μL of 
deionized water to remove cells not attached to the biofilm matriz. Then 200 μL of a 1% crystal violet 
(Merk) alcoholic solution was used to stain the biofilm present in each well. Following 15 minutes of 
incubation, each well was washed with 250 μL of deionized water. The stained biofilm was eluted in 
200 μL of 96% (v/v) ethanol and the absorbance of each well was read in a microplate reader at the 
wavelenght of 590nm (SPECTROstar Nano, BMG Labtech). 
3.8 – Subcellular localization of Dtr1 and Tpo4 transporter proteins 
C. glabrata cells harboring the pGREG576_MTI_CgDTR1 plasmid were grown to mid-
exponential phase in minimal medium, and then transferred to the same medium containing 1 M 
CuSO4. At a standard OD600nm of 0.5±0.05, obtained after around 5h of incubation, cells were 
inspected through fluorescence microscopy. S. cerevisiae cells harboring the pGREG576_CgDTR1 
plasmid were also tested considering the same standard OD600nm, obtained after around 5h of 
incubation with 1% galactose to induce protein expression. 
3.9- Statistical Analysis  
 Statistical analysis of the survival assays results were performed using the Mantel Cox test. 
For the rest, all data was analyzed with IBM® SPSS® Statistics version 23 by performing oneway 
ANOVA tests. P-values equal or inferior to 0,05 were considered statistically significant. 
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4. Results/Discussion 
  
 Results of this work are subjected to a confidentially agreement. Consequently they are 
presented in the confidentiality appendix, which are only available in the confidential version of the 
thesis. 
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